Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
0.8500
+0.0650 (8.28%)
At close: Sep 28, 2026
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $25.41 million as of September 28, 2026. Its market cap has decreased by -55.65% in one year.
Market Cap
25.41M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.85
ChartMarket Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 1.33M to 25.41M, an increase of 1,805.27%. That is a compound annual growth rate of 40.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 27.52M | 85,986,162.50% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 8,285.51% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 39.40M |
| Biomind Labs | 35.68M |
| ProText Mobility | 31.65M |
| Cell Source | 28.50M |
| Provectus Biopharmaceuticals | 22.91M |
| EOM Pharmaceuticals Holdings | 20.51M |
| Inhibitor Therapeutics | 17.38M |
| Finch Therapeutics Group | 16.62M |